Literature DB >> 21834693

Assessment of the Chinese-version SF-36 in the Chinese opiate addicts.

Shiyan Yan1, Zhi Lian, Guikuan Sun, Yanping Bao, Yun Ge, Zhimin Liu.   

Abstract

This study was designed to assess the reliability and validity of the Chinese version of the Medical Outcomes Study Short Form 36 (SF-36) assessed with opiate addicts in China. The sample was composed of 442 questionnaires from three regions in China, in 2004. The reliability of Chinese-version SF-36 was obtained using Cronbach's α and split-half coefficients and the validity was calculated using correlation analysis and confirmatory factor analysis method. The results of reliability and validity provide the first evidence that Chinese-version SF-36 is validated for Chinese addicts. The study's limitations are noted.

Entities:  

Mesh:

Year:  2011        PMID: 21834693     DOI: 10.3109/10826084.2011.589880

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  3 in total

1.  Psychometric evaluation of health related quality of life among rural-to-urban migrants in China.

Authors:  Peigang Wang; Cen Chen; Ronghua Yang; Yan Wu
Journal:  Health Qual Life Outcomes       Date:  2015-09-24       Impact factor: 3.186

2.  Health-related quality of life of COVID-19 patients after discharge: A multicenter follow-up study.

Authors:  Guangbo Qu; Qi Zhen; Wenjun Wang; Song Fan; Qibing Wu; Chengyuan Zhang; Bao Li; Gang Liu; Yafen Yu; Yonghuai Li; Liang Yong; Baojing Lu; Zhen Ding; Huiyao Ge; Yiwen Mao; Weiwei Chen; Qiongqiong Xu; Ruixue Zhang; Lu Cao; Shirui Chen; Haiwen Li; Hui Zhang; Xia Hu; Jing Zhang; Yonglian Wang; Hong Zhang; Chaozhao Liang; Liangdan Sun; Yehuan Sun
Journal:  J Clin Nurs       Date:  2021-03-17       Impact factor: 4.423

3.  Correlation Study of Short-Term Mental Health in Patients Discharged After Coronavirus Disease 2019 (COVID-19) Infection without Comorbidities: A Prospective Study.

Authors:  Lei Guo; Jingjing Lin; Weiyang Ying; Chanfan Zheng; Linshuang Tao; Binyu Ying; Bihuan Cheng; Shengwei Jin; Beilei Hu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-06       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.